StockData
BioAtla, Inc. logo

BioAtla, Inc. (BCAB) stock

BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 4/30
$1.31−0.05 (-3.68%)

Close on Oct 19, 2026Market cap $2.18MP/E –Yield –

BioAtla statistics

22 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
28.9%
10.9%
Shares Change (QoQ)
0.22%
0.51%
Shares Held by Institutions
11.2%
56.4%

Returns on capitalIndustry

Return on Assets (ROA)
-171.7%
-40.6%

Financial positionIndustry

Current Ratio
0.20
3.30
Quick Ratio
0.17
2.42

EfficiencyIndustry

Profits Per Employee
-$767.17K
-$683.67K
Employee Count
41
75

Income statement (TTM)Industry

Operating Income
-$32.13M
-$20.99M
Net Income
-$31.45M
-$21.61M
EBITDA
-$31.93M
-$16.85M
EPS (Diluted)
-$25.63
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$1.54M
$17.46M
Net Cash Per Share
$0.93
$0.72
Equity (Book Value)
-$36.24M
$53.27M
Book Value Per Share
-$21.75
$1.50
Tangible Book Value
-$36.24M
$26.82M
Working Capital
-$16.76M
$79.47M

Cash flow (TTM)Industry

Operating Cash Flow
-$23.48M
-$12.27M

Scores and fair valueIndustry

Piotroski F-Score
1
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodBCABS&P 500DifferenceBCAB per yearS&P 500 per year
1 month-26.8%+0.6%−27.4 pts
3 months-66.8%+3.4%−70.2 pts
Year to date-95.4%+13.3%−108.7 pts
1 year-96.8%+16.6%−113.5 pts
3 years-98.4%+86.4%−184.8 pts-74.9%+23.1%
5 years-99.9%+81.9%−181.8 pts-75.1%+12.7%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M BCAB shares were sold short on Oct 30, 2026, down 1.3% from the previous report. At recent volumes it would take 6.2 days to buy them back. Over the last 20 sessions, 48.9% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202671,975-1.3%11,5776.2
Oct 15, 202672,887-3.5%11,5066.3
Sep 30, 202675,558-19.7%54,6981.4
Sep 15, 202694,060-53.9%56,3691.7
Aug 31, 2026204,122+47.0%169,7311.2
Aug 14, 2026138,890+31.7%69,4122.0
Jul 31, 2026105,433-14.9%24,0914.4
Jul 15, 2026123,939-18.4%64,5761.9
Jun 30, 2026151,847-5.2%63,3512.4
Jun 15, 2026160,104+8.4%70,8062.3
May 29, 2026147,632-9.2%42,2593.5
May 15, 2026162,567+10.4%29,6055.5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?